Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Vitro Diagnostics (VODG) had Cash Flow from Financial Activities of $-0.03M for the most recently reported fiscal quarter, ending 2025-01-31.
| Income Statement Financials | |
$0.45M |
|
$-2.83M |
|
$0.09M |
|
$0.36M |
|
$2.30M |
|
$-1.85M |
|
$-0.99M |
|
$-2.83M |
|
$-2.83M |
|
$-2.83M |
|
$-2.83M |
|
$-2.83M |
|
$-2.83M |
|
$-1.85M |
|
$-1.74M |
|
4.46M |
|
4.46M |
|
$-0.64 |
|
$-0.64 |
|
| Balance Sheet Financials | |
$0.41M |
|
$0.10M |
|
$4.04M |
|
$4.45M |
|
$12.66M |
|
$1.09M |
|
$1.70M |
|
$14.36M |
|
$-9.91M |
|
$-13.52M |
|
$-9.91M |
|
4.46M |
|
| Cash Flow Statement Financials | |
$-0.43M |
|
$-0.00M |
|
|
Cash Flow from Financial Activities |
$-0.03M |
$0.57M |
|
$0.11M |
|
$-0.46M |
|
$0.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-0.12 |
|
-0.76 |
|
79.31% |
|
-410.23% |
|
-410.23% |
|
-- |
|
-630.10% |
|
-630.10% |
|
$-0.43M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.58 |
|
12.64 |
|
7.12 |
|
28.61% |
|
20.96% |
|
-63.75% |
|
32.16% |
|
$-2.22 |
|
$-0.10 |
|
$-0.10 |
|